Rademics Research Institute

Abstract

The rapid advancement of AI and genomic technologies has paved the way for innovative approaches in predicting disease susceptibility and personalizing treatment. This chapter explores the integration of AI in genomic sequencing, with a particular focus on the application of deep learning models, multi-omics data, and federated learning in clinical genomics. Key methods for identifying genetic markers and disease risk factors are discussed, along with the challenges associated with data diversity, model interpretability, and privacy concerns. Special emphasis was placed on the emerging role of AI-powered genomic platforms in early disease detection, highlighting case studies in cancer, cardiovascular diseases, neurological disorders, and rare genetic conditions. The chapter also addresses the importance of equitable AI model development through federated learning to mitigate population bias and ensure inclusivity across diverse demographic groups. By bridging the gap between computational genomics and clinical applications, this chapter provides insights into the transformative potential of AI in personalized medicine, while offering critical perspectives on the future directions and challenges in the field. 

Introduction

The integration of AI with genomic technologies was rapidly transforming the landscape of modern medicine, offering unprecedented opportunities for precision healthcare [1]. In recent years, advancements in genomic sequencing have generated vast amounts of biological data, providing deep insights into genetic factors that influence disease susceptibility [2]. Analyzing and interpreting these complex datasets presents significant challenges, requiring powerful computational tools capable of processing massive amounts of information [3]. AI has emerged as a key enabler, utilizing machine learning algorithms, particularly deep learning models, to extract meaningful patterns from genomic data [4]. This chapter explores the significant role of AI in genomic sequencing, shedding light on how these advanced technologies are reshaping disease prediction, risk assessment, and personalized treatment strategies [5]. AI-driven genomic platforms are particularly promising for identifying genetic variations associated with complex diseases such as cancer, cardiovascular disorders, and neurodegenerative diseases [6]. Traditionally, genomic research relied heavily on statistical methods to identify associations between genetic variants and disease traits, but these approaches often fell short in capturing intricate, nonlinear relationships within the data [7]. By leveraging deep learning techniques, AI models can now uncover hidden patterns and subtle genetic markers that contribute to disease onset [8]. AI can facilitate the integration of multi-omics data, combining genomic, transcriptomic, proteomic, and metabolomic information to offer a more comprehensive view of disease mechanisms [9,10]. This multi-dimensional approach enhances the accuracy of disease risk prediction, enabling more personalized and effective interventions for individuals.